Recent Advancements and Future Perspectives on Molecular Biomarkers in Adult Lower-Grade Gliomas
{{output}}
There has been a significant paradigm shift in the clinical management of lower-grade glioma patients given the recent updates to the 2021 World Health Organization classification along with long-term results from randomized phase III clinical trials. As a res... ...